Strategies and tools for the control/elimination of lymphatic filariasis

Bulletin of the World Health Organization

Volumn 75, Issue 6, 1997, Pages 491-503

  Ottesen, E A ^a   Duke, B O L ^a   Karam, M ^a   Behbehani, K ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLCARBAMAZINE; IVERMECTIN;

DISEASE CONTROL; FILARIASIS; LYMPHATIC FILARIASIS;

BRUGIA MALAYI; COST BENEFIT ANALYSIS; DRUG EFFICACY; FILARIASIS; GEOGRAPHIC DISTRIBUTION; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; PARASITE CONTROL; PARASITE TRANSMISSION; PATIENT SELECTION; REVIEW; WUCHERERIA BANCROFTI;

ADULT; AFRICA; ALBENDAZOLE; ANIMALS; ANTHELMINTICS; ASIA; CHILD; DIETHYLCARBAMAZINE; DRUG ADMINISTRATION SCHEDULE; ELEPHANTIASIS, FILARIAL; FEMALE; FILARICIDES; HUMANS; IVERMECTIN; MALE; MICROFILARIA; SUPERINFECTION;

AFRICA;

EID: 0031407451     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Michael E, Bundy DAP, Grenfell BT. Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology, 1996, 112: 409-428.
2. World health report 1995. Geneva, World Health Organization, 1995.
3. Ottesen E.A. The human filariases: new understandings, new therapeutic strategies. Current opinion in infectious diseases, 1994, 7: 550-558.
4. Dreyer G, Noroes J, Addiss D. The silent burden of sexual disability associated with lymphatic filariasis. Acta tropica, 1997, 63: 57-60.
5. CDC. Recommendations of the International Task Force for Disease Eradication. Morbidity and mortality weekly report, 1993, 42: 1-38.
6. Sasa M. Human filariasis: a global survey of epidemiology and control. Baltimore, MD, University Park Press, 1976.
7. Fan PC. Eradication of bancroftian filariasis on Kinmen (Quemoy) Islands, Republic of China: a review. Chinese journal of parasitology, 1993, 6: 51-69.
8. Sun Dejian. A great success in lymphatic filariasis control in China. Chinese journal of parasitology and parasitic diseases, 1995, 13: 81-85.
9. Kim JS, No BU, Lee WY. Brugian filariasis: 10-year follow-up study on the effectiveness of selective chemotherapy with diethylcarbamizine on Che Ju island, Republic of Korea. Bulletin of the World Health Organization. 1987, 65: 67-75.
10. Webber RH. Eradication of Wuchereria bancrofti infection through vector control. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1979, 73: 722-724.
11. Evans DB, Gelband H, Vlassoff C. Social and economic factors and the control of lymphatic filariasis: a review. Acta tropica, 1993, 53: 1-26.
12. Ramu K et al. Impact of lymphatic filariasis on the productivity of male weavers in a south Indian village. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1996, 90: 669-670.
13. Ramaiah KD et al. Epidemiology of acute filarial episodes caused by Wuchereria bancrofti infection in two rural villages in Tamil Nadu, South India. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1996, 90: 639-643.
14. WHO Expert Committee on Filariasis: fourth report. Geneva, World Health Organization, 1984 (WHO Technical Report Series 702).
15. Ottesen EA, Ramachandran CP. Lymphatic filariasis infection and disease: control strategies. Parasitology today, 1995, 11: 129-131.
16. Chodakewitz J. Ivermectin and lymphatic filariasis: a clinical update. Parasitology today, 1995, 11: 233-235.
17. Kumaraswami V et al. Ivermectin for the treatment of Wuchereria bancrofti filarisis: efficacy and adverse reactions. Journal of the American Medical Association, 1988, 259: 3150-3153.
18. Moulia-Pelat JP et al. Combination ivermectin plus diethylcarbamazine, a new effective tool for control of lymphatic filariasis. Tropical medicine and parasitology, 1995, 46: 9-12.
19. Wu-chun Cao et al. Ivermectin for chemotherapy of bancroftian filariasis: a meta-analysis of the effect of single treatment. Tropical medicine and international health, 1997, 2: 393-403.
20. Addiss DG et al. Comparative efficacy of clearing-dose and single high-dose ivermectin and diethylcarbamazine against Wuchereria bancrofti microfilaremia. American journal of tropical medicine and hygiene, 1993, 48: 178-185.
21. Dreyer G et al. Treatment of bancroftian filariasis in Recife, Brazil: a two-year comparative study of the efficacy of single treatments with ivermectin or diethylcarbamazine. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1995, 89: 98-102.
22. Hopkins D, Richards F. Visionary campaign: eliminating river blindness. In: Bernstein E, ed. 1997 Medical and health annual. Chicago; II, Encyclopedia Britannica Medical and Health Annual, 1997: 8-23.
23. Ottesen EA. Efficacy of diethylcarbamazine in eradicating infection with lymphatic-dwelling filariae in humans. Reviews of infectious diseases, 1985, 7: 341-356.
24. Dreyer G et al. Tolerance of diethylcarbamazine by microfilaraemic and amicrofilaraemic individuals in an endemic area of Bancroftian filariasis, Recife, Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1994, 88: 232-236.
25. Ottesen EA. Filarial infections. Infectious disease clinics of North America, 1993, 7: 619-633.
26. Gelband H. Diethylcarbamazine salt in the control of lymphatic filariasis. American journal of tropical medicine and hygiene, 1994, 50: 655-662.
27. Provincial Institute of Parasitic Diseases, Shantung. Field trial of control of bancroftian filariasis using common salt medicated with diethylcarbamazine. Chinese medical journal, 1976, 2: 365-371.
28. Subramanyam Reddy G, Venkateswaralu N. Mass administration of DEC-medicated salt for filariasis control in the endemic population of Karaikal, South India: implementation and impact assessment. Bulletin of the World Health Organization, 1996, 74: 85-90.
29. Meyrowitsch DW, Simonsen PE, Makunde WH. Mass diethylcarbamazine chemotherapy for control of bancroftian filariasis through community participation: comparative efficacy of a low monthly dose and medicated salt. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1996, 90: 74-79.
30. Savioli L et al. Intestinal worms beware: developments in anthelmintic chemotherapy usage. Parasitology today, 1997, 13: 43-44.
31. Kimura E. Penaia L, Spears GF. The efficacy of annual single-dose treatment with diethylcarbamazine citrate against diurnally subperiodic bancroftian filariasis in Samoa. Bulletin of the World Health Organization, 1985, 63: 1097-1106.
32. Partono F et al. Low dosage diethylcarbamazine administered by villagers for the control of timorian filariasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1984, 78: 370-372.
33. Laigret J, Fagneaux G, Tura E. Chimiothérapie de masse par la diethylcarbamazine en doses espacées: effects obtenus à Tahiti sur la microfilarémie à Wuchereria bancrofti, var. pacifica. Bulletin de l'Organisation mondiale de la Santé, 1980, 58: 779-783.
34. Mataika JU et al. Comparison of the efficacy of diethylcarbamazine between 5 rounds of annual single-dose treatment and an intensive 28-dose treatment spread over 2 years against diurnally subperiodic Wuchereria bancrofti in Fiji. Fiji medical journal, 1993, 19: 2-6.
35. Panicker KN et al. Comparison of effects of mass annual and biannual single dose therapy with diethylcarbamazine for the control of Malayan filariasis. Southeast Asian journal of tropical medicine and public health, 1991, 22: 402-411.
36. Bockarie MJ et al. Comparative efficacy of annual single-dose diethylcarbamazine (DEC) and DEC plus ivermectin (IVR) against Wuchereria bancrofti infection in humans and mosquitoes: community-wide, randomized trial. Lancet, (in press)
37. Ottesen EA. Immunological aspects of lymphatic filariasis and onchocerciasis in man. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1984, 78: 9-18.
38. Weil GJ et al. A monclonal antibody-based enzyme immunoassay for detecting parasite antigenaemia in Bancroftian filariasis. Journal of Infectious diseases, 1987, 156: 350-355.
39. Chanteau S et al. Og4C3 circulating antigen: a marker of infection and adult worm burden in Wuchereria bancrofti filariasis. Journal of infectious diseases, 1994, 170: 247-250.
40. Lammie PJ, Hightower AW, Eberhard ML. Age-specific prevalence of antigenemia in a Wuchereria bancrofti-exposed population. American journal of tropical medicine and hygiene, 1994, 51: 348-355.
41. McCarthy JS et al. Clearance of circulating filarial antigen as a measure of the macrofilaricidal activity of diethylcarbamazine in Wuchereria bancrofti infection. Journal of infectious diseases, 1995, 172: 521-526.
42. Weil GJ, Lammie PJ, Weiss N. The ICT filariasis test: a rapid format antigen test for diagnosis of Bancroftian filariasis. Parasitology today, (in press).
43. Lizotte MR et al. A PCR assay for the detection of Brugia malayi in blood. American journal of tropical medicine and hygiene, 1994, 51: 314-321.
44. Chanteau S et al. PCR-based detection of Wuchereria bancrofti larvae in pools of mosquitoes. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1994, 88: 665-666.
45. Gyapong J et al. Rapid community diagnosis of bancroftian filariasis. Acta tropica, 1996, 61: 65-74.
46. Addiss DG, Eberhard MI, Lammie PJ. "Filarial" adenolymptiangitis without filarial infection. Lancet, 1994, 343: 597.
47. Olzewski WL et al. Bacteriological studies of skin, tissue fluid and lymph in filarial lymphoedema. Lymphology, 1994, 27(suppl): 345-348.
48. Olszewki WL. Immunohistology of skin in various stages of filarial lymphedema. Lymphology, 1994, 27: 512-516.
49. Olszewki WL. Episodic dermatolymphangioadenitis (DLA) in patients with lymphedema of the lower extremities before and after administration of benzathine penicillin: a preliminary study. Lymphology, 1996, 29: 126-131.
50. Freedman DO et al. Lymphoscintigraphic analysis of lymphatic abnormalities in symptomatic and asymptomatic human filariasis. Journal of infectious diseases, 1994, 170: 927-933.
51. Dreyer G et al. Renal abnormalities in microfilaremic patients with Bancroftian filariasis. American journal of tropical medicine and hygiene, 1992, 46: 745-751.
52. Dreyer G et al. Ultrasonographic assessment of the adulticidal efficacy of repeat high-dose ivermectin in bancroftian filariasis. Tropical medicine and international health, 1996, 4: 427-432.
53. Ottesen EA. Filarasis. In: Bennett JC, Plum F, eds. Cecil textbook of medicine, 20th edit. Philadelphia, Saunders, 1996: 1939-1945.
54. Hougard JM et al. Campaign against Culex quinquefasciatus using Bacillus sphaericus: result of a pilot project in a large urban area of equatorial Africa. Bulletin of the World Health Organization, 1993, 71: 367-375.
55. Maxwell CA et al. Control of bancroftian filariasis by integrating therapy with vector control using polystyrene beads in wet pit latrines. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1990, 84: 709-714.
56. Bogh C et al. Permethrin-impregnated bednet effects on resting and feeding behaviour of lymphatic filariasis vector mosquitoes in Kenya. Medical and veterinary entomology, (in press).
57. Vasuki V, Rajavel AR. Beta-cyfluthrin, a synthetic pyrethroid for mosquito control. Southeast Asian journal of tropical medicine and public health, 1992, 23: 318-323.
58. Norman RA et al. The development of a dynamic model for describing the epidemiology of infection and disease in lymphatic filariasis. Parasitology (in press).
59. Plaisier AP et al. The LYMFASIM simulation program for modelling lymphatic firaliasis and its control. Methods of information in medicine (in press).
60. Remme JHF, Alley ES, Plaisier AP. Estimation and prediction in tropical disease control: the example of onchocerciasis. In: Mollison D, ed. Epidemic models: their structure and relation to data. Cambridge, Cambridge University Press, 1995: 372-392.
61. Ottesen EA, Campbell WC. Ivermectin in human medicine. Journal of antimicrobial chemotherapy, 1994, 34: 195-203.
62. Albonico M et al. A randomized controlled trial comparing mebendazole and albendazole against Ascaris, Trichuris and hookworm infections. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1994, 88: 585-589.
63. Addiss DG et al. Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrafti microfilaraemia in Haitian children. Lancet, 1997, 350:480-484.
64. Ismail MM et al. Treatment of bancraftion filariasis with ivermectin + albendazole. Transactions of the Royal Society of Tropical Medicine and Hygiene, (in press).